In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cobrek Pharmaceuticals Inc.

http://www.cobrek.com

Latest From Cobrek Pharmaceuticals Inc.

Deals Shaping The Medical Industry, February 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

ANDA Changes May Require Paragraph IV Recertification, New 30-Month Stay

Brand litigants are beginning to argue that post-Markman application tweaks are in essence new applications eligible for new 30-month stays.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • Drug Delivery
      • Topical Delivery
  • Other Names / Subsidiaries
    • Pentech Pharmaceuticals Inc.
UsernamePublicRestriction

Register